This Article  • Full text  • PDF  • CME Course for This Article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related letters  • Related article  • Similar articles in JAMA  Topic Collections  • Pain  • Cardiovascular System  • Diagnosis  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic  Social Bookmarking   What's this?

Anita Phan, MD, MA; Chrisandra Shufelt, MD, MS; C. Noel Bairey Merz, MD

JAMA. 2009;301(14):1468-1474.

Patients with persistent chest pain and no obstructive coronary artery disease are often labeled as having noncardiac pain and not offered further cardiologic testing or treatment. Diagnostic uncertainty for persistent chest pain is associated with adverse quality of life, morbidity, and health care costs. Two underdiagnosed cardiac causes for persistent chest pain include microvascular coronary disease and abnormal cardiac nociception. Microvascular coronary disease is associated with an increased risk of adverse cardiovascular events such as myocardial infarction, congestive heart failure, and sudden cardiac death, and treatment directed at improving endothelial function can improve outcomes. Abnormal cardiac nociception is also a cause for persistent chest pain caused by heightened coronary pain perception. Coronary reactivity testing allows for direct measurement of blood flow characteristics in response to vasoactive agents for the diagnoses of microvascular coronary disease and can be a useful tool to differentiate causes of chest pain. Coronary reactivity testing is an invasive method for assessing coronary vascular function, with current evidence suggesting that its associated risk is relatively low compared with the adverse prognosis associated with microvascular coronary dysfunction. Accurate diagnosis in patients with persistent chest pain and normal coronary arteries can be challenging and deserves adequate investigation in light of the associated morbidity, mortality, and health care costs.

Author Affiliations: Division of Cardiology, Department of Medicine, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTERS

Evaluating Patients With Persistent Chest Pain and No Obstructive Coronary Artery Disease

JAMA. ;302():622-622.
FULL TEXT  

Evaluating Patients With Persistent Chest Pain and No Obstructive Coronary Artery Disease
and
JAMA. ;302():622-623.
FULL TEXT  

RELATED ARTICLE

Chest Pain
, , and
JAMA. ;301():1498-1498.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Assessment of Structural Disease in the Coronary Microvasculature
Ganz and Hsue
Circulation 2009;120:1555-1557.
FULL TEXT  

Evaluating Patients With Persistent Chest Pain and No Obstructive Coronary Artery Disease
Seiden
JAMA 2009;302:622-622.
FULL TEXT  

Evaluating Patients With Persistent Chest Pain and No Obstructive Coronary Artery Disease
Beltrame and Ganz
JAMA 2009;302:622-623.
FULL TEXT